- Report
- January 2026
- 183 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 192 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 191 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 198 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 181 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 181 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 187 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 198 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- November 2025
- 194 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- August 2025
- 199 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- August 2025
- 199 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 180 Pages
Global
From €3938EUR$4,500USD£3,423GBP
- Report
- June 2025
- 186 Pages
Global
From €3938EUR$4,500USD£3,423GBP
- Report
- November 2025
- 180 Pages
Global
From €3938EUR$4,500USD£3,423GBP
- Report
- April 2025
- 400 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- April 2025
- 250 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- April 2025
- 200 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- April 2025
- 200 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- April 2025
- 200 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- April 2025
- 200 Pages
Global
From €3930EUR$4,490USD£3,416GBP

The Cardiac Valve market is a segment of the Cardiovascular Devices industry, which includes a range of products used to diagnose and treat heart conditions. Cardiac valves are used to regulate the flow of blood through the heart, and can be either mechanical or biological. Mechanical valves are typically made of metal and are designed to last for many years, while biological valves are made of animal tissue and are designed to be replaced over time. Both types of valves are used to treat a variety of heart conditions, including aortic stenosis, mitral regurgitation, and tricuspid regurgitation.
The Cardiac Valve market is highly competitive, with a number of companies offering a range of products. Major players in the market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and LivaNova. Other companies in the market include CryoLife, Symetis, and Neovasc. Show Less Read more